Format

Send to

Choose Destination
Intensive Care Med. 2000 Dec;26(12):1730-9.

Intravenous amiodarone in intensive care. Time for a reappraisal?

Author information

1
Department of Anaesthetics, Royal Infirmary, Glasgow, Scotland. mh4493@compuserve.com

Abstract

Amiodarone is widely used in intensive care units for the treatment of a variety of arrhythmias. It is currently the drug of choice for supraventricular tachyarrhythmias in many units because of its combination of efficacy and safety. This review summarises the current state of knowledge regarding the short-term administration of intravenous amiodarone to control arrhythmias in perioperative, coronary care and intensive care patients. It outlines the electrophysiology, haemodynamics, pharmacokinetics and toxicity of the drug. In particular, it examines the recent concerns regarding acute pulmonary toxicity.

PMID:
11271079
DOI:
10.1007/s001340000668
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center